Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXAZEPAM vs OXITRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OXAZEPAM vs OXITRIPTAN: Safety Overview

Metric OXAZEPAM OXITRIPTAN
Total FAERS Reports 12,440 100
Deaths Reported 2,965 5
Death Rate 23.8% 5.0%
Hospitalizations 6,242 34
Average Patient Age 57.3 yrs 52.2 yrs
% Female Patients 58.3% 58.6%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Aphena Pharma Solutions - Tennessee, LLC Energique, Inc.
Route ORAL ORAL
Marketing Status Discontinued N/A